Corvus Pharmaceuticals, Inc. (CRVS)
16.74
+1.70
(+11.30%)
USD |
NASDAQ |
Apr 17, 16:00
16.84
+0.10
(+0.60%)
After-Hours: 20:00
Corvus Pharmaceuticals Free Cash Flow : -32.97M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Regeneron Pharmaceuticals, Inc. | 3.765B |
| Plus Therapeutics, Inc. | -20.84M |
| Geron Corp. | -110.95M |
| Nektar Therapeutics | -208.68M |
| Jaguar Health, Inc. | -23.73M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -9.191M |
| Cash from Investing (Quarterly) | 10.88M |
| Cash from Financing (Quarterly) | 0.02M |
| Free Cash Flow Per Share (Quarterly) | -0.1111 |
| Free Cash Flow to Equity (Quarterly) | -9.142M |
| Free Cash Flow to Firm (Quarterly) | -9.216M |
| Free Cash Flow Yield | -2.47% |